Primary Category:
Treatment Protocols
Disease Category:
Head and Neck, Head and Neck Metastatic
Status:
New, Open
Randomized Phase 2 Study of Nivolumab and Ipilimumab with or Without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
NCT#05904080
